Results 71 to 80 of about 11,011 (206)

Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma

, 2015
Theresa R Prosser, Suzanne G Bollmeier St Louis College of Pharmacy, St Louis, MO, USA Background: The purpose of this systematic review is to summarize and evaluate the available published data regarding the efficacy and safety of a combination ...
Prosser, Theresa R., Bollmeier, Suzanne G., Bollmeier SG, Prosser TR   +3 more
core   +1 more source

Formoterol Acting via β2-Adrenoreceptor Restores Mitochondrial Dysfunction Caused by Parkinson’s Disease-Related UQCRC1 Mutation and Improves Mitochondrial Homeostasis Including Dynamic and Transport

Biology
Formoterol, a β2-adrenergic receptor (β2AR) agonist, shows promise in various diseases, but its effectiveness in Parkinson’s disease (PD) is debated, with unclear regulation of mitochondrial homeostasis.
Jui-Chih Chang, Huei-Shin Chang, Yi-Chun Chao, Ching-Shan Huang, Chin-Hsien Lin, Zhong-Sheng Wu, Hui-Ju Chang, Chin-San Liu, Chieh-Sen Chuang   +8 more
doaj   +1 more source

Tiotropium Add-On and Treatable Traits in Asthma-COPD Overlap: A Real-World Pilot Study

Journal of Asthma and Allergy, 2022
Yoshihisa Ishiura,1 Masaki Fujimura,2 Noriyuki Ohkura,3 Johsuke Hara,3 Kahori Nakahama,1 Yusuke Sawai,1 Takeshi Tamaki,1 Ryuta Murai,1 Toshiki Shimizu,1 Naoyuki Miyashita,1 Shosaku Nomura1 1First Department of Internal Medicine, Kansai Medical University,
Ishiura Y, Fujimura M, Ohkura N, Hara J, Nakahama K, Sawai Y, Tamaki T, Murai R, Shimizu T, Miyashita N, Nomura S   +10 more
doaj  

Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial

BMC Pulmonary Medicine, 2012
Background This study investigated the efficacy and safety of a new asthma therapy combining fluticasone propionate and formoterol fumarate (fluticasone/formoterol; flutiform®), administered twice daily (b.i.d.) via a single aerosol inhaler, compared ...
Nathan Robert A, D’Urzo Anthony, Blazhko Viktor, Kaiser Kirsten   +3 more
doaj   +1 more source

Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis

, 2016
Adjuvant-induced arthritis is an experimental model of rheumatoid arthritis that is associated with body weight loss and muscle wasting. β2-adrenergic receptor agonists are powerful anabolic agents that trigger skeletal muscle hypertrophy and have been ...
Gómez Moreira, Carolina, Fernández Galaz, María Del Carmen, Villanúa Bernués, María Ángeles, Martín Velasco, Ana Isabel, Gómez San Miguel, Ana Belén, Nieto Bona, María Paz, López-Calderón Barreda, Asunción   +6 more
core   +1 more source

Hearing the Unusual: A Rare Otological Case of IgG4‐Related Disease Treated With Steroids and Inebiluzmab

ACR Open Rheumatology, Volume 8, Issue 5, May 2026.
Yuanzun Peng, Muhammad Zaheer
wiley   +1 more source

Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol

International Journal of COPD, 2017
Vaidyanathan Ganapathy,1 Michael D Stensland2 1Sunovion Pharmaceuticals Inc., Marlborough, MA, 2Agile Outcomes Research, Inc., Rochester, MN, USA Objective: Arformoterol is the (R,R)-enantiomer of formoterol.
Ganapathy V, Stensland MD
doaj  

Cost-effectiveness of budesonide-formoterol in maintenance therapy of asthma patients at Mexico’s National Center for Respiratory Diseases.

Revista Alergia México
Objective: to perform a cost-effectiveness analysis of asthma treatment with budesonide/formoterol against other treatment options used at Mexico’s National Institute for Respiratory Diseases.
María del Carmen Cano-Salas, José L. Miguel-Reyes, Erika C. López-Estrada, Jorge Salas-Hernández, Monserrat E. Arroyo-Rojas, Mauricio Castañeda-Valdivia, Monserrat Escobar-Preciado, Homero Garcés-Flores, Silvia Guzmán- Vázquez, Sergio R. García-García, Herman Soto-Molina   +10 more
doaj   +1 more source

Resposta broncodilatadora imediata ao formoterol em doença pulmonar obstrutiva crônica com pouca reversibilidade Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease

Jornal Brasileiro de Pneumologia, 2008
OBJETIVO: Avaliar, por meio de provas de função pulmonar, a eficácia broncodilatadora do formoterol após 30 min de sua administração em portadores de doença pulmonar obstrutiva crônica (DPOC) com pouca reversibilidade.
Adalberto Sperb Rubin, Fábio José Fabrício de Barros Souza, Jorge Lima Hetzel, José da Silva Moreira   +3 more
doaj   +1 more source

Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review.

, 2011
BACKGROUND: Interactions between spirometry and patient-reported outcomes in COPD are not well understood. This systematic review and study-level analysis investigated the relationship between changes in FEV1 and changes in health status with ...
PW, Jones, Worthy, G, Annamaria Cerulli, Jones, PW, Capkun-Niggli Gorana, Cerulli, A, Worthy Gill, Jean Bourbeau, Westwood, M, Cerulli Annamaria, Westwood Marie, Gorana Capkun-Niggli, Gill Worthy, Bourbeau, J, Paul W Jones, Capkun-Niggli, G, Jones Paul W, Bourbeau Jean, Marie Westwood   +18 more
core   +1 more source